The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

Fiber Deployment
Connected America 2025: Smarter Planning and Partnerships Key to Maximizing Fiber’s Federal Funding and Impact
March 31, 2025

As the digital divide accelerates and fiber deployment sees growth, Connected America 2025 has emerged as a pivotal moment for infrastructure professionals. With over $42.5 billion earmarked through federal programs like the Broadband Equity, Access, and Deployment (BEAD) initiative, the U.S. is undergoing one of the most aggressive broadband expansion efforts in its history….

Read More
Workplace safety
Building a Skilled Trades Workforce: Certifications, Simulation-Based Training & Reskilling with SkillCat
March 31, 2025

Industries across the United States are facing an unprecedented shortage of a skilled trades workforce. With millions of baby boomers retiring and fewer young people entering the trades, sectors like HVAC, manufacturing, and construction are grappling with a critical need for talent. This labor shortage is further compounded by a lack of awareness and…

Read More
K-12 school
Tackling All That K-12 Schools Try to Do: The Solutions
March 31, 2025

As public confidence in major institutions continues to erode, the American K–12 education system finds itself straining under the weight of legacy expectations and modern demands. From grading and college recommendations to extracurriculars and character development, K-12 schools are tasked with a near-impossible mission: to do it all, for everyone. At the same time,…

Read More
wellness
The Rise of AI-Powered Wellness: Vitaquest Taps Big Data to Deliver Personalized Nutrition at Scale
March 31, 2025

The wellness industry is at an inflection point. What once centered around pill packs and generic supplement regimens is now being transformed by an ecosystem of personalization, flavor innovation, and data-driven development. According to research, the global nutraceuticals market is on track to surpass $919 billion by 2030—and with consumer demand increasingly favoring tailored,…

Read More